
Tenecteplase in Acute Ischemic Stroke
Pharmacy to Dose: The Critical Care Podcast
The Importance of Differentiating Studies
The European guidelines have an expedited recommendation come out using all this evidence and feels like we may be waiting a while for the AHA, ASA guidelines to update. What I think about to look at is are these mild strokes that are looking at are these moderate or severe strokes? And I think that's going to make a difference. We'll talk about how some of these studies really highlighted that. It can be easy to feel lost or that the study studies can kind of run together or feel very similar, but yet different in your mind. The quality of evidence went from low to moderate and the strength went from weak to strong on all these big things. So really important thing.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.